Parkinson’s reversal? One drug brings dying brain cells back to life

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, tin regrow mislaid cellular “antennae” successful cardinal encephalon cells, restoring captious dopamine connection and neuroprotective signals successful a rodent exemplary of familial Parkinson’s. After 3 months connected the LRRK2-blocking cause MLi-2, damaged circuits revived and aboriginal signs of neuronal betterment emerged, hinting that timely attraction could not lone halt but reverse illness progression—and possibly payment different Parkinson’s forms.